ATE235225T1 - Neue arzneimittel enthaltend uridintriphosphat - Google Patents
Neue arzneimittel enthaltend uridintriphosphatInfo
- Publication number
- ATE235225T1 ATE235225T1 AT98965462T AT98965462T ATE235225T1 AT E235225 T1 ATE235225 T1 AT E235225T1 AT 98965462 T AT98965462 T AT 98965462T AT 98965462 T AT98965462 T AT 98965462T AT E235225 T1 ATE235225 T1 AT E235225T1
- Authority
- AT
- Austria
- Prior art keywords
- products containing
- medicinal products
- uridine triphosphate
- new medicinal
- containing uridine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/996,740 US5968913A (en) | 1996-07-03 | 1997-12-23 | Pharmaceutical compositions of uridine triphosphate |
| PCT/US1998/027409 WO1999032085A2 (en) | 1997-12-23 | 1998-12-23 | Novel pharmaceutical compositions of uridine triphosphate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE235225T1 true ATE235225T1 (de) | 2003-04-15 |
Family
ID=25543248
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98965462T ATE235225T1 (de) | 1997-12-23 | 1998-12-23 | Neue arzneimittel enthaltend uridintriphosphat |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5968913A (de) |
| EP (1) | EP1041969B1 (de) |
| JP (1) | JP2001526208A (de) |
| KR (1) | KR20010033310A (de) |
| CN (1) | CN1143672C (de) |
| AR (1) | AR014176A1 (de) |
| AT (1) | ATE235225T1 (de) |
| AU (1) | AU747350B2 (de) |
| BR (1) | BR9814426A (de) |
| CA (1) | CA2316018A1 (de) |
| DE (1) | DE69812708T2 (de) |
| ID (1) | ID26137A (de) |
| IL (1) | IL136895A0 (de) |
| NO (1) | NO20003246L (de) |
| NZ (1) | NZ505821A (de) |
| WO (1) | WO1999032085A2 (de) |
| ZA (1) | ZA9811833B (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6319908B1 (en) | 1996-07-03 | 2001-11-20 | Inspire Pharmaceuticals, Inc. | Method for large-scale production of di(uridine 5′-tetraphosphate) and salts thereof |
| US5763447C1 (en) | 1996-07-23 | 2002-05-07 | Inspire Pharmaceuticals | Method of preventing or treating pneumonia in immobilized patients with uridine triphosphates and related compounds |
| BRPI9810436B1 (pt) | 1997-07-25 | 2015-12-29 | Inspire Pharmaceuticals Inc | processo para a produção em larga escala de di (5'-tetrafosfato de uridina) e sais do mesmo |
| US6872710B2 (en) * | 1997-07-25 | 2005-03-29 | Inspire Pharmaceuticals, Inc. | Di(uridine 5′)-tetraphosphate and salts thereof |
| TW593331B (en) | 1997-07-25 | 2004-06-21 | Inspire Pharmaceuticals Inc | Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof |
| US7132408B2 (en) | 2000-08-21 | 2006-11-07 | Inspire Pharmaceuticals, Inc. | Composition and method for inhibiting platelet aggregation |
| US7018985B1 (en) | 2000-08-21 | 2006-03-28 | Inspire Pharmaceuticals, Inc. | Composition and method for inhibiting platelet aggregation |
| US7452870B2 (en) * | 2000-08-21 | 2008-11-18 | Inspire Pharmaceuticals, Inc. | Drug-eluting stents coated with P2Y12 receptor antagonist compound |
| US6327215B1 (en) * | 2000-09-28 | 2001-12-04 | Vanguard International Semiconductor Corporation | Local bit switch decode circuit and method |
| US7109181B2 (en) | 2001-06-25 | 2006-09-19 | Inspire Pharmaceuticals, Inc. | Joint lubrication with P2Y purinergic receptor agonists |
| TW200300692A (en) * | 2001-11-06 | 2003-06-16 | Inspire Pharmaceuticals Inc | Method for treating or preventing inflammatory diseases |
| EP1560540A4 (de) * | 2002-10-18 | 2008-03-19 | Molichem Medicines Inc | Verfahren zur behandlung trockener augen mit lantibiotika |
| WO2005107787A1 (en) * | 2004-05-06 | 2005-11-17 | Molichem Medicines, Inc. | Treatment of membrane-associated diseases and disorders using lantibiotic containing compositions |
| US7479481B2 (en) * | 2004-05-06 | 2009-01-20 | Molichem Medicines, Inc. | Treatment of ocular diseases and disorders using lantibiotic compositions |
| US7368439B2 (en) * | 2005-06-15 | 2008-05-06 | Bar - Ilan University | Dinucleoside poly(borano)phosphate derivatives and uses thereof |
| US20120077778A1 (en) * | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
| ES2640485T3 (es) | 2011-08-12 | 2017-11-03 | Universitätsklinikum Freiburg | Uridina y análogos de uridina para el uso en el tratamiento de la enfermedad pulmonar obstructiva crónica |
| US9034442B2 (en) * | 2012-11-30 | 2015-05-19 | Corning Incorporated | Strengthened borosilicate glass containers with improved damage tolerance |
| US10117806B2 (en) * | 2012-11-30 | 2018-11-06 | Corning Incorporated | Strengthened glass containers resistant to delamination and damage |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB916309A (en) * | 1959-12-14 | 1963-01-23 | Ile Auguil Soc Civ | Improvements in and relating to new therapeutic preparation for use as a muscular and nervous stimulant |
| JPS60126220A (ja) * | 1983-12-09 | 1985-07-05 | Otsuka Pharmaceut Factory Inc | 核酸成分組成物 |
| GB9027968D0 (en) * | 1990-12-22 | 1991-02-13 | Fisons Plc | Method of treatment |
| US5164740A (en) * | 1991-04-24 | 1992-11-17 | Yehuda Ivri | High frequency printing mechanism |
| FR2677250B1 (fr) * | 1991-06-05 | 1995-01-20 | Synthelabo | Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique. |
| EP0517573A1 (de) * | 1991-06-05 | 1992-12-09 | Synthelabo | Pharmazeutische Zusammensetzungen zur Behandlung von Atemwegserkrankungen |
| US5292498A (en) * | 1991-06-19 | 1994-03-08 | The University Of North Carolina At Chapel Hill | Method of treating lung disease with uridine triphosphates |
| US5518179A (en) * | 1991-12-04 | 1996-05-21 | The Technology Partnership Limited | Fluid droplets production apparatus and method |
| US5547131A (en) * | 1992-12-04 | 1996-08-20 | Bespak Plc | Dispensing device with spray nozzle and driven piston |
| US5497763A (en) * | 1993-05-21 | 1996-03-12 | Aradigm Corporation | Disposable package for intrapulmonary delivery of aerosolized formulations |
| US5593824A (en) * | 1994-09-02 | 1997-01-14 | Pharmacia Biotech, Inc. | Biological reagent spheres |
| US5628984A (en) * | 1995-07-31 | 1997-05-13 | University Of North Carolina At Chapel Hill | Method of detecting lung disease |
| US6423694B1 (en) * | 1996-02-21 | 2002-07-23 | Inspire Pharmaceuticals, Inc. | Method of treating otitis media with uridine triphosphates and related compounds |
| DE69736468T2 (de) * | 1996-03-27 | 2007-03-29 | Inspire Pharmaceuticals, Inc. | Verfahren zur behandlung der ziliardyskinesie mit uridintriphosphaten und verwandten verbindungen |
| US5789391A (en) * | 1996-07-03 | 1998-08-04 | Inspire Pharmaceuticals, Inc. | Method of treating sinusitis with uridine triphosphates and related compounds |
| US5962432A (en) * | 1996-07-03 | 1999-10-05 | Inspire Pharmaceuticals, Inc. | Sterilized, isotonic and pH-adjusted pharmaceutical formulation of uridine triphosphate |
| US5763447C1 (en) * | 1996-07-23 | 2002-05-07 | Inspire Pharmaceuticals | Method of preventing or treating pneumonia in immobilized patients with uridine triphosphates and related compounds |
| US6159952A (en) * | 1996-11-07 | 2000-12-12 | Inspire Pharmaceuticals, Inc. | Method of treating bronchitis with uridine triphosphate and related compounds |
-
1997
- 1997-12-23 US US08/996,740 patent/US5968913A/en not_active Expired - Lifetime
-
1998
- 1998-12-23 JP JP2000525079A patent/JP2001526208A/ja active Pending
- 1998-12-23 AR ARP980106670A patent/AR014176A1/es not_active Application Discontinuation
- 1998-12-23 NZ NZ505821A patent/NZ505821A/xx unknown
- 1998-12-23 DE DE69812708T patent/DE69812708T2/de not_active Expired - Fee Related
- 1998-12-23 BR BR9814426-0A patent/BR9814426A/pt not_active IP Right Cessation
- 1998-12-23 ID IDW20001428A patent/ID26137A/id unknown
- 1998-12-23 CA CA002316018A patent/CA2316018A1/en not_active Abandoned
- 1998-12-23 AU AU20922/99A patent/AU747350B2/en not_active Ceased
- 1998-12-23 WO PCT/US1998/027409 patent/WO1999032085A2/en active IP Right Grant
- 1998-12-23 ZA ZA9811833A patent/ZA9811833B/xx unknown
- 1998-12-23 KR KR1020007006756A patent/KR20010033310A/ko active IP Right Grant
- 1998-12-23 IL IL13689598A patent/IL136895A0/xx unknown
- 1998-12-23 EP EP98965462A patent/EP1041969B1/de not_active Expired - Lifetime
- 1998-12-23 AT AT98965462T patent/ATE235225T1/de not_active IP Right Cessation
- 1998-12-23 CN CNB988136228A patent/CN1143672C/zh not_active Expired - Fee Related
-
2000
- 2000-06-21 NO NO20003246A patent/NO20003246L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BR9814426A (pt) | 2001-10-23 |
| DE69812708D1 (de) | 2003-04-30 |
| AU2092299A (en) | 1999-07-12 |
| NO20003246L (no) | 2000-08-23 |
| NO20003246D0 (no) | 2000-06-21 |
| IL136895A0 (en) | 2001-06-14 |
| WO1999032085A2 (en) | 1999-07-01 |
| KR20010033310A (ko) | 2001-04-25 |
| CN1143672C (zh) | 2004-03-31 |
| NZ505821A (en) | 2002-09-27 |
| AR014176A1 (es) | 2001-02-07 |
| CN1284861A (zh) | 2001-02-21 |
| EP1041969B1 (de) | 2003-03-26 |
| DE69812708T2 (de) | 2004-01-29 |
| AU747350B2 (en) | 2002-05-16 |
| CA2316018A1 (en) | 1999-07-01 |
| JP2001526208A (ja) | 2001-12-18 |
| ID26137A (id) | 2000-11-23 |
| ZA9811833B (en) | 1999-07-20 |
| WO1999032085A3 (en) | 1999-09-02 |
| US5968913A (en) | 1999-10-19 |
| EP1041969A2 (de) | 2000-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE235225T1 (de) | Neue arzneimittel enthaltend uridintriphosphat | |
| ATE202472T1 (de) | Arzneimittel enthaltend oxaliplatin | |
| NO962606L (no) | Farmasöytisk sammensetning | |
| DK1001813T3 (da) | Farmaceutiske formuleringer indeholdende voriconazol | |
| ATE240732T1 (de) | Ziprasidonhaltige arzneimittel | |
| NO20002359L (no) | Adenosinderivater og farmasoytisk sammensetning inneholdende derivatene | |
| CY2005007I1 (el) | Φαρμακευτικες συνθεσεις που περιεχουν δαριφενακινη | |
| BR9611626A (pt) | Formulações farmacéuticas | |
| DK0920302T4 (da) | Farmaceutisk aerosolsammensætning | |
| NO20000231D0 (no) | Dolastatin-15-derivater | |
| BR9610214A (pt) | Compostos farmacéuticos | |
| DE59801987D1 (de) | Pharmazeutische zusammensetzung enthaltend peptichemio | |
| DE69820861D1 (de) | Teilchenförmige arzneimittelträger | |
| LV11727A (lv) | Farmaceitiska kompozicija | |
| ID29294A (id) | Komposisi farmasi | |
| BR9507768A (pt) | Composição farmacêutica | |
| NO20003141D0 (no) | Farmasøytiske blandinger | |
| FI973280A0 (fi) | Farmaseuttinen koostumus | |
| ATE269337T1 (de) | Trizyclische delta3-pyridine als arzneimittel | |
| DE60008237D1 (de) | Lamivudin enthaltende arzneimittel | |
| NO965448L (no) | Farmasöytiske forbindelser | |
| BR9605777A (pt) | Composição farmacêutica | |
| ID23531A (id) | Komposisi farmasi | |
| NO964309D0 (no) | Farmasöytisk sammensetning | |
| IT1272935B (it) | Composizione farmaceutica contenente n-acetil-cisteina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |